Literature DB >> 23196103

St. John's Wort, an anti-depressant? A systematic, criteria-based review.

E Ernst1.   

Abstract

The aim of this review was to assess controlled clinical trials of Hypericum as a treatment for depression. A systematic, combined computer and hand search revealed fourteen studies conducted against placebo and four against standard medication. Eight of the former and three of the latter met the predetermined methodological inclusion criteria and were admitted for analysis. The cumulative data shows that Hypericum is superior to placebo in alleviating symptoms of depression as quantified by the Hamilton Scale. It also seems equally effective as standard medication; the frequency of adverse drug reactions shows a clear advantage of the herbal over synthetic antidepressants. It is concluded that Hypericum is a safe and effective symptomatic treatment for various forms of depressions.
Copyright © 1995 Gustav Fischer Verlag, Struttgart · Jena · New York. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Year:  1995        PMID: 23196103     DOI: 10.1016/S0944-7113(11)80051-6

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.

Authors:  Feng Chen; Amir H Rezvani; Andrew J Lawrence
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

Review 2.  St John's wort for major depression.

Authors:  Klaus Linde; Michael M Berner; Levente Kriston
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 3.  Systematic reviews of complementary therapies - an annotated bibliography. Part 2: herbal medicine.

Authors:  K Linde; G ter Riet; M Hondras; A Vickers; R Saller; D Melchart
Journal:  BMC Complement Altern Med       Date:  2001-07-20       Impact factor: 3.659

4.  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].

Authors:  Shahin Akhondzadeh; Hasan Fallah-Pour; Khosro Afkham; Amir-Hossein Jamshidi; Farahnaz Khalighi-Cigaroudi
Journal:  BMC Complement Altern Med       Date:  2004-09-02       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.